Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FECBUD trial of budesonide or placebo induction before fecal microbiota transplantation in ulcerative colitis
NL-OMON44482Withdrawn
- Sponsor
- Haaglanden Medical Centre
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in autoimmune colitis and inflammatory bowel disease (IBD) comparing Budesonide induction followed by FMT with Placebo induction followed by FMT (2 arms). Planned start Jan 2018; status: withdrawn.
02
Drugs
budesonideallogeneic fecal microbiota
03
Conditions
autoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON44482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44482.